Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

新型胰高血糖素样肽-1类似物—索马鲁肽

Xin-li ZHANG,Fa-ming DING,Mao-shan YIN

The Chinese Journal of Clinical Pharmacology（2018）

Cited 0|Views8
No score
Abstract
胰高血糖素样肽-1(GLP-1)受体激动剂一直是糖尿病治疗领域中备受瞩目的多肽类产品.索马鲁肽为长效GLP-1受体激动药,于2017年12月获得美国食品药品监督管理局(FDA)批准.本文对索马鲁肽的药学信息、药理毒理及临床试验数据进行了概括,并对其疗效及安全性进行了讨论,希望为医患用药提供借鉴.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined